We are pleased to announce the seventh in our series of meetings on mitochondrial disorders and the search for novel effective therapies.

Mitochondrial disorders have emerged as a major cause of inherited human disease. There is a growing appreciation that new treatments will emerge through collaborations between clinicians, laboratory scientists and the life sciences industry, based on a firm understanding of the disease mechanisms. This conference aims to bring these groups together.

The conference will build new partnerships that harness our understanding of the disease mechanisms, accelerating the pace of effective treatments for mitochondrial diseases. This year’s meeting will include discussions to improve clinical trial readiness, an update on data analysis for multi-omic studies, the role of mitochondria in cancer, and we will explore the links between disease phenotypes and treatments. We will also focus on how patients can be at the heart of clinical trials.

We will bring together leaders in the field of translational mitochondrial medicine, with a programme designed to engage and inspire the next generation of mitochondrial researchers. The meeting attracts international participants interested in mitochondrial diseases, working in genomics, biochemistry, pathology and clinical medicine.